Congenital malformations are estimated to be present in 13% of all admissions to neonatal intensive care units (NICUs) in developed countries
1,2 and remain the leading cause of neonatal mortality (estimated at 20%-34%).
3,4 While cytogenetic abnormalities
5 and copy number variants (CNVs)
6 are known causes of birth defects in seriously ill neonates, single-gene disorders are also significant contributors.
7-11 The diagnostic tests for the clinical evaluation of newborns with suspected genetic diseases have expanded exponentially in recent years, particularly with the institution of next-generation sequencing (NGS). As the overall burden of genetic disorders in neonates is being explored via implementation of genome-wide sequencing in newborn screening programs,
12-14 clinical geneticists and neonatologists are in a unique position to initiate evidence-based studies in large tertiary care centers, deliver care that combines state-of-the-art diagnostic tools and genetic counseling, and provide reproductive options regarding serious genetic diseases in at-risk families.